These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 34363016)

  • 1. Genetic testing in ambulatory cardiology clinics reveals high rate of findings with clinical management implications.
    Murdock DR; Venner E; Muzny DM; Metcalf GA; Murugan M; Hadley TD; Chander V; de Vries PS; Jia X; Hussain A; Agha AM; Sabo A; Li S; Meng Q; Hu J; Tian X; Cohen M; Yi V; Kovar CL; Gingras MC; Korchina V; Howard C; Riconda DL; Pereira S; Smith HS; Huda ZA; Buentello A; Marino PR; Leiber L; Balasubramanyam A; Amos CI; Civitello AB; Chelu MG; Maag R; McGuire AL; Boerwinkle E; Wehrens XHT; Ballantyne CM; Gibbs RA
    Genet Med; 2021 Dec; 23(12):2404-2414. PubMed ID: 34363016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient and Clinician Perceptions of Precision Cardiology Care: Findings From the HeartCare Study.
    Smith HS; Sanchez CE; Maag R; Buentello A; Murdock DR; Metcalf GA; Hadley TD; Riconda DL; Boerwinkle E; Wehrens XHT; Ballantyne CM; Gibbs RA; McGuire AL; Pereira S
    Circ Genom Precis Med; 2022 Dec; 15(6):e003605. PubMed ID: 36282588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-interventional cardiologists' perspectives on the role of pharmacogenomic testing in cardiovascular medicine.
    Deininger KM; Page RL; Lee YM; Kauffman YS; Johnson SG; Oreschak K; Aquilante CL
    Per Med; 2019 Mar; 16(2):123-132. PubMed ID: 30543145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding role of pharmacogenomics in the management of cardiovascular disorders.
    Yip VL; Pirmohamed M
    Am J Cardiovasc Drugs; 2013 Jun; 13(3):151-62. PubMed ID: 23579966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Description of Pharmacogenomic Testing Among Patients Admitted to the Intensive Care Unit After Cardiovascular Surgery.
    Peterson PE; Nicholson WT; Moyer AM; Arendt CJ; Smischney NJ; Seelhammer TG; Krecke CA; Haney RM; Yaw EJ; Chlan LL
    J Intensive Care Med; 2021 Nov; 36(11):1281-1285. PubMed ID: 32734840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does cardiology hold pharmacogenetics to an inconsistent standard? A comparison of evidence among recommendations.
    Luzum JA; Cheung JC
    Pharmacogenomics; 2018 Oct; 19(15):1203-1216. PubMed ID: 30196751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.
    Winkelmann BR; März W; Boehm BO; Zotz R; Hager J; Hellstern P; Senges J;
    Pharmacogenomics; 2001 Feb; 2(1 Suppl 1):S1-73. PubMed ID: 11258203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol.
    Bielinski SJ; Olson JE; Pathak J; Weinshilboum RM; Wang L; Lyke KJ; Ryu E; Targonski PV; Van Norstrand MD; Hathcock MA; Takahashi PY; McCormick JB; Johnson KJ; Maschke KJ; Rohrer Vitek CR; Ellingson MS; Wieben ED; Farrugia G; Morrisette JA; Kruckeberg KJ; Bruflat JK; Peterson LM; Blommel JH; Skierka JM; Ferber MJ; Black JL; Baudhuin LM; Klee EW; Ross JL; Veldhuizen TL; Schultz CG; Caraballo PJ; Freimuth RR; Chute CG; Kullo IJ
    Mayo Clin Proc; 2014 Jan; 89(1):25-33. PubMed ID: 24388019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases.
    Zhu Y; Swanson KM; Rojas RL; Wang Z; St Sauver JL; Visscher SL; Prokop LJ; Bielinski SJ; Wang L; Weinshilboum R; Borah BJ
    Genet Med; 2020 Mar; 22(3):475-486. PubMed ID: 31591509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of pharmacogenetic testing into medication therapy management.
    Haga SB; Moaddeb J; Mills R; Patel M; Kraus W; Allen LaPointe NM
    Pharmacogenomics; 2015 Nov; 16(17):1931-41. PubMed ID: 26555559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Personalized therapy in cardiology. Biomarkers, pharmacogenetics and therapy of monogenic diseases].
    Eschenhagen T; Blankenberg S
    Internist (Berl); 2013 Feb; 54(2):147-8, 150-2, 154. PubMed ID: 23371262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testing.
    Haga SB; O'Daniel JM; Tindall GM; Mills R; Lipkus IM; Agans R
    Clin Genet; 2012 Aug; 82(2):115-20. PubMed ID: 22283474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing.
    Duarte JD; Dalton R; Elchynski AL; Smith DM; Cicali EJ; Lee JC; Duong BQ; Petry NJ; Aquilante CL; Beitelshees AL; Empey PE; Johnson JA; Obeng AO; Pasternak AL; Pratt VM; Ramsey LB; Tuteja S; Van Driest SL; Wiisanen K; Hicks JK; Cavallari LH;
    Genet Med; 2021 Dec; 23(12):2335-2341. PubMed ID: 34282303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders.
    Hess GP; Fonseca E; Scott R; Fagerness J
    Genet Res (Camb); 2015 Jun; 97():e13. PubMed ID: 26030725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Horizon Scan Of Clinical Laboratories Offering Pharmacogenetic Testing.
    Haga SB; Kantor A
    Health Aff (Millwood); 2018 May; 37(5):717-723. PubMed ID: 29733708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting.
    Cohn I; Manshaei R; Liston E; Okello JBA; Khan R; Curtis MR; Krupski AJ; Jobling RK; Kalbfleisch K; Paton TA; Reuter MS; Hayeems RZ; Verstegen RHJ; Goldman A; Kim RH; Ito S
    JAMA Netw Open; 2021 May; 4(5):e2110446. PubMed ID: 34037732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact.
    van der Wouden CH; Bank PCD; Özokcu K; Swen JJ; Guchelaar HJ
    Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?
    Verbelen M; Weale ME; Lewis CM
    Pharmacogenomics J; 2017 Oct; 17(5):395-402. PubMed ID: 28607506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes toward pharmacogenetics in patients undergoing
    Lee G; Varughese LA; Conway L; Stojinski C; Ashokkumar S; Monono K; Matthai W; Kolansky DM; Giri J; Tuteja S
    Per Med; 2022 Mar; 19(2):93-101. PubMed ID: 34984913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Utility of Pharmacogenetic Testing and a Clinical Decision Support Tool to Enhance the Identification of Drug Therapy Problems Through Medication Therapy Management in Polypharmacy Patients.
    Kim K; Magness JW; Nelson R; Baron V; Brixner DI
    J Manag Care Spec Pharm; 2018 Dec; 24(12):1250-1259. PubMed ID: 30479202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.